Chiome Bioscience Inc. (4583.T)
JPY 272.0
(-3.2%)
JPY 272.0
(-3.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.06 Billion | -1.19 Billion | -1.13 Billion | -1.36 Billion | -1.53 Billion |
| Net Income | -1.21 Billion | -1.23 Billion | -1.46 Billion | -1.29 Billion | -1.4 Billion |
| Depreciation & Amortization | 1.2 Million | 1.47 Million | 2.95 Million | 3.7 Million | 4.84 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 99.64 Million | 51.42 Million | 143.71 Million | -38.36 Million | -139.57 Million |
| Other non-cash items | 42.92 Million | -23.73 Million | 29.78 Million | -35.84 Million | 1.19 Million |
| Investing Cash Flow | 173 Thousand | - | -35.38 Million | -3.51 Million | -26.42 Million |
| Investments in PPE | 1.06 Billion | - | - | - | - |
| Acquisitions | 173 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | -26.42 Million |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 173 Thousand | - | -35.38 Million | -3.51 Million | -26.42 Million |
| Financing Cash Flow | 667.3 Million | 1.12 Billion | 271.34 Million | 1.94 Billion | 1.34 Billion |
| Debt repayment | -107 Million | -1 Million | -3 Million | -180 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 554.51 Million | 1.12 Billion | 253.77 Million | 1.76 Billion | 1.34 Billion |
| Other Financing Activities | 5.78 Million | -1000.00 | 14.56 Million | -5.93 Million | 1.34 Billion |
| Accounts receivables | 32.02 Million | -89.76 Million | 31.32 Million | 38.36 Million | -52.83 Million |
| Accounts payables | 5.86 Million | 2.05 Million | -10.29 Million | 10.17 Million | -1.95 Million |
| Inventory | 7.37 Million | -12.48 Million | 30.21 Million | -22.63 Million | -21.21 Million |
| Other working capital | 97.3 Million | 132.49 Million | 122.26 Million | -64.26 Million | -65.53 Million |
| Cash at beginning of period | 1.72 Billion | 1.79 Billion | 2.68 Billion | 2.1 Billion | 2.32 Billion |
| Cash at end of period | 1.32 Billion | 1.72 Billion | 1.79 Billion | 2.68 Billion | 2.1 Billion |
| Capital Expenditure | 1.06 Billion | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -401.71 Million | -63.71 Million | -895.33 Million | 580.34 Million | -222.53 Million |
| Free Cash Flow | - | -1.19 Billion | -1.13 Billion | -1.36 Billion | -1.53 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -259.93 Million | -304.02 Million | -301.55 Million | -1.21 Billion | -254.81 Million | -435.97 Million |
| Depreciation & Amortization | - | - | - | 1.2 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | -654 Thousand | - |
| Change in working capital | - | - | - | 99.64 Million | - | - |
| Other non-cash items | 259.93 Million | 304.02 Million | 301.55 Million | 42.92 Million | 255.46 Million | 435.97 Million |
| Investing Cash Flow | - | - | - | 173 Thousand | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | 173 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 173 Thousand | - | - |
| Financing Cash Flow | - | - | - | 667.3 Million | - | - |
| Debt repayment | - | - | - | -107 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 554.51 Million | - | - |
| Other Financing Activities | - | - | - | 5.78 Million | - | - |
| Accounts receivables | - | - | - | 32.02 Million | - | - |
| Accounts payables | - | - | - | 5.86 Million | - | - |
| Inventory | - | - | - | 7.37 Million | - | - |
| Other working capital | - | - | - | 97.3 Million | - | - |
| Cash at beginning of period | - | - | - | 1.72 Billion | - | - |
| Cash at end of period | - | - | - | 1.32 Billion | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | -401.71 Million | - | - |
| Free Cash Flow | - | - | - | -1.06 Billion | - | - |
2507
MTL
000838
R35
HNL
AOMD